Jan 15, 2026 7:30 am EST Mount Sinai Becomes First in Metro New York to Deliver Incision-Free, MRI-Guided Prostate Treatment with TULSA-PRO®
Dec 23, 2025 8:00 am EST Profound Medical Corp. Closes $36 Million Registered Direct Offering; Expects to Complete Subsequent Private Placement On or Before December 30th
Dec 19, 2025 8:45 am EST Profound Medical Corp. Announces Pricing of up to $40 Million Financing Comprised of a $36 Million Registered Direct Offering and a Subsequent $4 Million Private Placement
Dec 4, 2025 5:00 pm EST Stanford Medicine’s Dr. Pejman Ghanouni Receives RSNA’s Cum Laude Award for CAPTAIN Perioperative Data Presentation
Nov 28, 2025 7:45 am EST Profound Medical to Launch AI-Powered BPH Module, Present New TULSA-PRO® Clinical Data, at RSNA and SUO Meetings
Nov 18, 2025 4:15 pm EST Profound Medical Celebrates The Hong Center’s 200th Independent TULSA Procedure for Prostate Disease